Edition:
United Kingdom

Prophase Labs Inc (PRPH.OQ)

PRPH.OQ on NASDAQ Stock Exchange Capital Market

3.00USD
19 Jul 2018
Change (% chg)

$0.02 (+0.67%)
Prev Close
$2.98
Open
$2.99
Day's High
$3.00
Day's Low
$2.99
Volume
1,028
Avg. Vol
7,343
52-wk High
$6.63
52-wk Low
$2.01

Chart for

About

ProPhase Labs, Inc. manufactures, markets and distributes a range of homeopathic and healthcare products. The Company is engaged in the research and development of over-the-counter (OTC) drugs and natural base health products, including supplements, personal care and cosmeceutical products. The Company's products include TK... (more)
No analyst recommendations are available for .

Overall

Beta: 0.16
Market Cap(Mil.): $33.79
Shares Outstanding(Mil.): 16.17
Dividend: --
Yield (%): --

Financials

  PRPH.OQ Industry Sector
P/E (TTM): 2.48 22.52 40.76
EPS (TTM): 0.84 -- --
ROI: 56.84 12.26 62.30
ROE: 56.84 15.63 73.91

BRIEF-Prophase Labs Announces Special Cash Dividend

* BOARD OF DIRECTORS HAS DECLARED A SPECIAL CASH DIVIDEND IN AMOUNT OF $1.00 PER SHARE ON ITS COMMON STOCK Source text for Eikon: Further company coverage:

08 May 2018

BRIEF-Prophase Labs Announces New Compensatory Arrangement With CEO And Termination Of Stockholder Rights Plan

* PROPHASE LABS, INC. ANNOUNCES NEW COMPENSATORY ARRANGEMENT WITH CHIEF EXECUTIVE OFFICER AND TERMINATION OF STOCKHOLDER RIGHTS PLAN

21 Feb 2018

Earnings vs. Estimates

No consensus analysis data available.